Skip to main content
Toggle navigation
Login
Search
Home
Tweets by 2023 SSO Annual Meeting
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Speaker
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
O
O’Riordan, Marie
University Hospitals of Leicester NHS Trust, Leicester, UK
62: Validation of Invasive Area for Predicting Sentinel Node Status and Survival in Melanoma
Location:Veterans Memorial Auditorium
Marie O’Riordan
Oba, Takaaki
Roswell Park Cancer Institute
94: Single-cell profiling of tumor-infiltrating T-cell clones in longitudinal peripheral blood samples for clinical studies
Location:Ballroom A
Takaaki Oba
Obeng-Gyasi, Samilia
The Ohio State University
P5: Allostatic Load as a New Predictor of Postoperative Complications in Oncology Patients
Location:SSO HUB: Breast & Endocrine Zone
Samilia Obeng-Gyasi
Questions and Discussion
Location:Ballroom C
Samilia Obeng-Gyasi
Research Regarding Allostatic Load and Cancer Disparities
Location:Ballroom C
Samilia Obeng-Gyasi
Obonyo, Marygorret
Department of Medicine, University of California San Diego
P83: Primary and Metastatic Gastric Cancers in Patient-derived Orthotopic Xenografts Brightly Labeled by Fluorescent anti-CEA Antibody
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Marygorret Obonyo
Odell, David
Northwestern University Feinberg School of Medicine
P70: A call for more equitable care in colon cancer: The association between racial and socioeconomic disparities and hospital quality
Location:SSO HUB: Rare/Metastatic Cancers Zone
David Odell
P71: Are Pathologic Factors Associated with Higher Risk for Venous Thromboembolism After Gastrointestinal Cancer Surgery? A Potential Opportunity to Tailor Prophylaxis
Location:SSO HUB: Rare/Metastatic Cancers Zone
David Odell
Ogayo, Esther
Dana-Farber Cancer Institute
2: Racial disparities in locoregional recurrence in patients with stage I-III, hormone receptor positive breast cancer enrolled in the NSABP B-42 trial
Location:Veterans Memorial Auditorium
Esther Ogayo
Ogbevire, Yoma
UTSW
72: Cost Analysis and Financial Implications of Cytoreductive Surgery and HIPEC: a US Single Center Experience
Location:Ballroom B
Yoma Ogbevire
Ogier, Charline
Fox Chase Cancer Institute
50: Anti-Netrin-1 Therapy Inhibits Metastasis and Improves Survival in Pancreatic Cancer
Location:Ballroom A
Charline Ogier
Olariu, Radu
Department of Plastic and Hand Surgery, Inselspital University Hospital Bern, Freiburgstrasse, Switzerland
77: Current Patterns of Care and Outcomes for Dermatofibrosarcoma Protuberans: An International Multi-institutional Collaborative
Location:Ballroom A
Radu Olariu
Olecki, Elizabeth
Pennsylvania State College of Medicine
103: Endoscopic-assisted Laparoscopic Transgastric Partial Gastrectomy for Gastroesophageal Junction Gastrointestinal Stromal Tumor
Location:Veterans Memorial Auditorium
Elizabeth Olecki
Olino, Kelly
Yale School of Medicine
64: Lifileucel TIL Cell Therapy in Patients With Advanced Melanoma After Progression on Immune Checkpoint Inhibitors (ICI) and Targeted Therapy: Tumor Tissue Procurement Data from the C-144-01 Study
Location:Veterans Memorial Auditorium
Kelly Olino
Questions and Discussion
Location:Ballroom A
Kelly Olino
The Use of ctDNA in the Management of Cutaneous Malignancies: Current Use and Future Directions
Location:Ballroom A
Kelly Olino
Olofsson Bagge, Roger
Department of Surgery, Sahlgrenska University Hospital, Sweden
56: International Validation Study of the Melanoma Institute Australia Sentinel Node Metastasis Risk Nomogram
Location:Veterans Memorial Auditorium
Roger Olofsson Bagge
Olson, Brian
Emory University
55: Neoadjuvant Pepinemab in Combination with Nivolumab and/or Ipilimumab in Resectable Stage III Melanoma
Location:Veterans Memorial Auditorium
Brian Olson
Olson, Madeline
OncoNano Medicine
65: Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH Sensitive Imaging Agent: Topline Results from a Phase 2 Study
Location:Veterans Memorial Auditorium
Madeline Olson
Olszewski, Michal
University of Michigan Medical School
P46: Histotripsy ablation abrogates tumor hypoxia and induces immunogenic cancer cell death
Location:SSO HUB: Melanoma & Sarcoma Zone
Michal Olszewski
Omer, Dana
Department of Surgery, Memorial Sloan Kettering Cancer Center
21: Organ Preservation, Compliance and Toxicity in Rectal Cancer Patients Treated with Total Neoadjuvant Therapy: A Post Hoc Analysis of the of the OPRA Phase II Trial
Location:Ballroom C
Dana Omer
Onesti, Jill
Trinity Health St. Mary's
HPB Poster Presentations 3
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Jill Onesti
Which Practice Setting is Best for Me? Exploring all the Options
Location:SSO HUB Theater
Jill Onesti
Ong, Cecilia
Department of Surgery, Section of General Surgery and Surgical Oncology, University of Chicago Medical Center. Chicago
P53: Therapeutic Implications of Germline Testing in Peritoneal Mesothelioma
Location:SSO HUB: Rare/Metastatic Cancers Zone
Cecilia Ong
Ongchin, Melanie
University of Pittsburgh Medical Center
73: Predicting Early Recurrence to optimize Patient Selection for Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy in High-Grade Appendiceal Mucinous Carcinoma Peritonei
Location:Ballroom B
Melanie Ongchin
P52: Impact of Primary Tumor Location and Genomic Alterations on Survival Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Colorectal Peritoneal Metastases
Location:SSO HUB: Rare/Metastatic Cancers Zone
Melanie Ongchin
Ong, Cynthia
Virginia Commonwealth University School of Medicine
13: Luminal A vs B After Choosing Wisely: Do Phenotypes Affect Oncologic Outcomes?
Location:Veterans Memorial Auditorium
Cynthia Ong
Onuma, Amblessed
The Ohio State University Wexner Medical Center
P59: Comparing complete compartmental resection with tumor only resection of retroperitoneal soft tissue sarcoma using the win ratio
Location:SSO HUB: Melanoma & Sarcoma Zone
Amblessed Onuma
Orcutt, Sonia
University of Arkansas for Medical Sciences
83: Adherence to and outcomes of extended venous thromboembolism prophylaxis after complex gastrointestinal cancer surgery
Location:Veterans Memorial Auditorium
Sonia Orcutt
Orme, Sophie
Norfolk & Norwich University Hospitals NHS Trust, Norwich, UK
62: Validation of Invasive Area for Predicting Sentinel Node Status and Survival in Melanoma
Location:Veterans Memorial Auditorium
Sophie Orme
Oseni, Tawakalitu
Harvard Medical School, Massachusetts General Hospital
P66: Medicaid Expansion Increases Early Lung Cancer Diagnosis in Urban Blacks
Location:SSO HUB: Rare/Metastatic Cancers Zone
Tawakalitu Oseni
Ostowari, Arsha
University of California, Irvine
P49: Convolutional Neural Network to Predict Peritoneal Carcinomatosis Risk in Gastric Cancer
Location:SSO HUB: Rare/Metastatic Cancers Zone
Arsha Ostowari
P50: Novel Vascularized Microtumor (VMT) Model of Peritoneal Carcinomatosis (PC) with Mesothelial-Lined Chambers and Submesothelial Stroma that Mimic the Peritoneal Cavity
Location:SSO HUB: Rare/Metastatic Cancers Zone
Arsha Ostowari
Ostrander, Brian
OncoNano Medicine
65: Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH Sensitive Imaging Agent: Topline Results from a Phase 2 Study
Location:Veterans Memorial Auditorium
Brian Ostrander
Othus, Megan
University of Washington
53: Surgical Outcomes of SWOG1801: Neoadjuvant/adjuvant versus adjuvant pembrolizumab for resectable stage III-IV melanoma
Location:Veterans Memorial Auditorium
Megan Othus
Ott, Patrick
Dana Farber Cancer Institute
The Next Generation of Vaccination Approaches to the Treatment of Cancer: mRNA and Designer Cancer Vaccines
Location:SSO HUB: Immuno-Oncology Zone
Patrick Ott
Owusu-Brackett, Nicci
The Ohio State University
82: Socioeconomic Disparities in the Treatment and Survival of Extremity Soft Tissue Sarcoma
Location:Ballroom B
Nicci Owusu-Brackett
P5: Allostatic Load as a New Predictor of Postoperative Complications in Oncology Patients
Location:SSO HUB: Breast & Endocrine Zone
Nicci Owusu-Brackett
Oyedeji, Abimbola
Washington University in St. Louis
22: The Long non-coding RNA RAMS11 Promotes Chemotherapy Resistance in-vivo in Metastatic Colorectal Cancer.
Location:Ballroom C
Abimbola Oyedeji
Ozmen, Tolga
Massachusetts General Hospital, Harvard Medical School
Breast Poster Presentations 1
Location:SSO HUB: Breast & Endocrine Zone
Tolga Ozmen
Back to Top
